The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Palmer Ashleigh since 2010.
This trader's CIK number is 1493714.
At the time of last reporting, Palmer Ashleigh was the Director and CEO of Provention Bio, Inc.. (stock ticker symbol PRVB).
Also see all insider trading activities at Provention Bio, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | PRVB | 0 | $0 | 100,000 | $1,013,063 | 100,000 | $249,999 |
| 2021 | PRVB | 3,750 | $24,990 | 0 | $0 | 0 | $0 |
| 2020 | PRVB | 3,300 | $42,269 | 0 | $0 | 0 | $0 |
| 2019 | PRVB | 19,675 | $189,084 | 0 | $0 | 0 | $0 |
| 2018 | PRVB | 43,325 | $159,953 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | UGNE | 10,000 | $5,280 | 0 | $0 | 0 | $0 |
| 2010 | UGNE | 50,000 | $34,802 | 0 | $0 | 0 | $0 |
1. Provention Bio, Inc. (PRVB)
2. Unigene Laboratories Inc (UGNE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-10 | PRVB | Option Ex | 50,000 | 2.50 | 125,000 |
| 2023-02-10 | PRVB | Sale | 50,000 | 10.11 | 505,550 |
| 2023-02-13 | PRVB | Option Ex | 25,835 | 2.50 | 64,587 |
| 2023-02-13 | PRVB | Sale | 25,835 | 10.04 | 259,460 |
| 2023-01-18 | PRVB | Sale | 24,165 | 10.27 | 248,053 |
| 2023-01-18 | PRVB | Option Ex | 24,165 | 2.50 | 60,412 |
| 2021-11-30 | PRVB | Buy | 3,750 | 6.66 | 24,990 |
| 2020-08-18 | PRVB | Buy | 500 | 12.69 | 6,345 |
| 2020-08-17 | PRVB | Buy | 2,800 | 12.83 | 35,924 |
| 2019-12-20 | PRVB | Buy | 2,075 | 11.39 | 23,634 |
| 2019-09-24 | PRVB | Buy | 3,000 | 8.38 | 25,140 |
| 2019-08-08 | PRVB | Buy | 10,600 | 9.15 | 96,990 |
| 2019-06-18 | PRVB | Buy | 4,000 | 10.83 | 43,320 |
| 2018-12-28 | PRVB | Buy | 5,000 | 1.73 | 8,650 |
| 2018-12-31 | PRVB | Buy | 825 | 1.58 | 1,303 |
| 2018-07-19 | PRVB | Buy | 37,500 | 4.00 | 150,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-12-21 | UGNE | Buy | 10,000 | .53 | 5,280 |
| 2010-09-20 | UGNE | Buy | 8,800 | .70 | 6,160 |
| 2010-08-12 | UGNE | Buy | 20,000 | .60 | 12,000 |
| 2010-06-18 | UGNE | Buy | 21,200 | .79 | 16,642 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palmer Ashleigh (Director and CEO of Provention Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.